Skip to main content

Why cost effectiveness analysis is important in public health

Cost-effectiveness analysis (CEA) is a method used in health economics and healthcare planning to compare the costs and benefits of different healthcare interventions. CEA is particularly important in public health because it helps policymakers and healthcare providers to make informed decisions about which interventions to prioritise and invest in. 

Vaccination is a good example of why incremental CEA is important. Vaccination programmes can be expensive, and policymakers need to know if the benefits of vaccination outweigh the costs. Incremental CEA can help answer this question by comparing the costs and health outcomes of vaccination to other interventions, or to doing nothing at all. 

There are many factors that can affect the cost-effectiveness of a public health intervention. These include the cost of the intervention, the effectiveness of the intervention, and the value of the health outcomes that are achieved (such as a reduction in hospital admissions or an improvement in quality of life). The cost of an intervention can vary depending on a number of factors, such as the resources that are needed to implement the intervention, the number of people who are affected by the intervention, and the cost of any associated treatment or care.

The effectiveness of an intervention can also vary depending on the characteristics of the population that is being targeted. In general, public health programmes are more cost-effective in people with a higher risk of poor health outcomes. This is why older people are often targeted for such interventions (for example, Covid-19 vaccine boosters). By using incremental CEA, policymakers can identify which public health programmes provide the most health benefits for the lowest cost. They can also use this information to determine the optimal allocation of resources and funding to achieve the best population health outcomes. 

Additionally, by comparing the cost-effectiveness of different public health strategies, they can make more informed decisions about which interventions to prioritize and invest in, helping to maximize the overall impact of limited public health resources. As well as vaccination, we can also use CEA to look at other public health programme such as screening for cancer, interventions to promote healthy diets and increase physical activity, and programmes to support people to quit smoking.


Comments

Popular posts from this blog

Example ADHD Referral Letter

Dear Dr, I am writing to refer a 28-year-old male patient of mine, Mr [Patient's Name], for assessment for the diagnosis and treatment of Attention Deficit Hyperactivity Disorder (ADHD). After a thorough clinical assessment, I believe that Mr. [Patient's Name] meets the criteria for adult ADHD as outlined in NHS guidance for primary care teams in SE London. Mr [Patient's Name] has been under my care for XX years and, during this time, he reports several symptoms (greater than five symptoms in total) consistent with ADHD in adults that have been present for more than six months. These symptoms include difficulties in focusing, following through on tasks, hyperactivity, forgetfulness, impulsiveness, restlessness, and irritability. Mr [Patient's Name] also reports being easily distracted, struggling with time management, organisation, and completing tasks efficiently. Many of Mr [Patient's Name]'s symptoms have been present since he was under 12 years old; and have

Dr Curran and Partners – Clinical Update 10 August 2023

1. Measles The UKHSA has warned that unless MMR vaccination rates improve, London could experience a large measles outbreak. Measles is potentially a very serious illness with important complications - but is preventable though vaccination.  Please ensure patients and their families are up to date with their vaccinations. Please also check the vaccine status of new patients - particular migrants - and enter details onto the medical record of any vaccines given elsewhere. https://www.gov.uk/government/news/london-at-risk-of-measles-outbreaks-with-modelling-estimating-tens-of-thousands-of-cases 2. Shingles vaccination The shingles vaccine programme is being expanded. From September, GP practices will offer: - Those aged 70-79, 1 dose of Zostavax or 2 doses of Shingrix - People aged 50+ with a weak immune system, 2 doses of Shingrix - Those turning 65 & 70, two doses of Shingrix vaccine. For further details, see https://www.gov.uk/government/publications/shingles-vacc

How can we work successfully across the health and care system to make a success of Pharmacy First?

Pharmacies in England to begin treating patients for seven common conditions. How can we work successfully across the health and care system to make a success of Pharmacy First? 1. The Pharmacy First scheme aims to provide convenient access to healthcare through community pharmacies. Patients with minor ailments or common conditions can seek advice and treatment directly from their local pharmacy instead of visiting a general practice, urgent care centre or emergency department. The conditions covered by the scheme may vary depending on local funding arrangements and participation of pharmacies.  2, A potential problem with Pharmacy First is pharmacists misdiagnosing a patient's condition. It may also lead to delays in patients seeing doctors when medical assessment is needed. To mitigate these risks, appropriate safeguards and referral pathways should be established, ensuring timely medical assessment when necessary. The scheme will also increase the workload of pharmacies, thereb